Funding Announcements

"We've hit a tipping point. Process orchestration is no longer a niche idea; it's a core foundation of digital transformation and AI deployment. Enate is an established pioneer of this movement. SEP's backing is a huge validation. They're experienced growth equity investors with a strong track record in enterprise software. This is about scaling up with the right partner, strengthening our product and AI capabilities, and taking Enate to even more service providers globally."

"Some challenges were uniquely Indian, like the high dependence on cash-on-delivery, which has an abuse problem leading to major revenue leakage,"

"As more and more models launch, devs can have tens or even hundreds of endpoints to integrate with and maintain. Runware solves this problem by delivering access to all the models, at the best price, with the best inference time. We see model providers now moving to our platform and offering their APIs from our inference pod, because we can deliver 90% lower inference cost than any cloud provider."

"OutSee’s Nomaly technology is a truly next-generation genomic analysis tool with potential to transform drug discovery using powerful data-driven insights. It allows us to interrogate smaller datasets, and even data that has already been analysed, to uncover unique target insights that until now would have remained undetected."

"We founded Giles AI to dramatically accelerate clinical and medical research using secure, cutting-edge, conversational AI. The impact is transformative: a typical 10-year, $1.5bn drug or device development pipeline can be accelerated significantly – getting life-saving innovations to market faster than ever before. With our collaboration with Google, our recent £750K pre-seed raise gives us the runway to scale rapidly -FounderCatalyst were instrumental facilitating the raise, providing expert legal guidance and an incredibly efficient process that let us stay focused on building the future of medical research."